Elicio Therapeutics ELTX Balance Sheet (2019-2026)

NASDAQ ELTX
$1.63 +0.02 (+1.24%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Elicio Therapeutics Quarterly Balance Sheet

Periods 28 quarters
Latest Sep 2026

Elicio Therapeutics reported total assets of $39.60M and total liabilities of $20.75M for the quarter ended Sep 2026, up 40.0% year over year. This balance sheet covers 28 quarters of results from Dec 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
88.76M73.00M0.60M1.84M6.16M8.57M21.68M14.84M12.89M11.85M3.43M26.02M17.62M18.35M22.09M20.61M18.56M14.95M23.50M30.90M
Cash & Current Investments
88.76M73.00M0.60M1.84M6.16M8.57M21.68M14.84M12.89M11.85M3.43M26.02M17.62M18.35M22.09M20.61M18.56M14.95M23.50M30.90M
Receivables - NetNet Receivables
9.68M
Receivables - OtherOther Receivables
0.81M
Receivables
9.68M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
1.69M3.24M2.51M1.54M2.92M1.73M4.54M3.42M2.73M1.61M2.87M3.31M1.90M1.90M0.51M0.85M0.75M1.25M2.01M3.14M
Current Assets
91.25M76.24M65.89M56.68M10.72M40.63M26.23M19.93M16.35M14.13M6.69M30.65M20.69M20.94M22.60M21.47M19.31M16.20M25.49M34.04M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.45M0.42M0.39M0.30M1.15M0.92M0.77M0.72M0.64M0.60M0.52M0.48M0.43M0.38M0.33M0.30M0.25M0.21M0.18M
Long-Term Investments
0.72M0.73M0.87M0.87M0.87M0.15M
Long-Term Deferred Tax
Other Non-Current Assets
0.11M0.08M0.09M0.08M3.45M0.86M3.52M3.52M3.52M3.39M2.32M1.29M1.30M1.30M1.30M1.50M1.50M1.71M1.34M1.34M
Non-Current Assets
5.27M5.02M4.93M4.64M11.95M1.14M11.39M11.06M10.80M10.35M9.06M7.74M7.49M7.21M6.93M6.82M6.55M6.49M5.85M5.56M
Assets
96.51M81.26M70.81M61.32M22.66M41.77M37.62M30.99M27.15M24.48M15.75M38.39M28.18M28.14M29.53M28.28M25.86M22.69M31.33M39.60M
Liabilities
Current Liabilities
Accounts Payables
4.71M3.43M2.66M2.22M2.81M0.69M4.27M4.41M4.37M1.11M1.06M1.98M1.04M4.04M3.87M0.32M0.67M0.27M0.84M0.38M
Notes Payables
0.69M0.99M0.94M0.91M0.88M0.85M0.88M0.90M0.93M0.95M0.98M1.01M1.04M1.07M1.11M
Payables
4.71M3.43M2.66M2.22M3.50M0.69M5.25M5.34M5.28M1.99M1.91M2.86M1.94M4.96M4.82M1.30M1.68M1.31M1.91M1.48M
Accumulated Expenses
3.22M5.24M4.09M4.91M1.94M1.10M2.32M4.42M3.76M3.32M5.32M4.85M8.42M5.77M5.11M5.21M6.43M5.92M7.29M5.97M
Other Accumulated Expenses
0.89M0.92M0.94M0.97M0.99M0.23M
Short term Debt
2.48M
Current Leases
0.06M0.06M0.06M0.06M0.07M
Current Deferred Revenue
2.30M0.65M1.44M1.66M0.69M0.63M0.40M1.31M1.17M0.68M
Total Current Liabilities
11.30M10.38M7.78M8.18M6.87M2.03M7.60M11.49M9.76M5.95M7.59M9.02M11.52M11.41M9.92M6.52M8.11M7.23M9.20M9.93M
Non-Current Liabilities
Capital Leases
0.24M0.22M0.20M0.19M0.17M
Non-Current Debt
20.03M9.34M9.72M9.41M9.48M9.54M7.16M
Convertible Debt
19.84M20.03M
Non-Current Deferred Revenue
Preferred Stock Liabilities
70.44M70.44M71.61M80.45M111.06M111.06M
Operating Leases
3.48M3.24M2.99M2.74M6.79M0.07M6.42M6.22M6.01M5.79M5.57M5.34M5.11M4.87M4.61M4.36M4.09M3.82M3.54M3.25M
Other Non-Current Liabilities
0.22M0.08M0.02M0.01M0.03M0.03M0.01M7.87M4.25M23.18M2.83M2.96M3.82M3.88M2.62M3.60M1.12M0.41M
Total Non-Current Liabilities
171.05M162.47M159.35M156.99M124.81M151.63M14.03M17.68M15.76M11.74M13.15M34.19M36.66M16.28M23.87M20.59M21.61M20.53M22.28M20.34M
Total Liabilities
171.05M162.69M159.43M157.01M124.81M151.64M14.06M17.70M15.77M19.61M17.40M57.37M39.49M19.24M27.69M24.47M24.23M24.13M23.39M20.75M
Shareholder's Equity
Total Debt
0.69M0.99M0.94M0.91M0.88M0.85M0.88M20.94M0.93M10.29M10.70M10.42M10.52M10.61M10.74M
Common Equity
-74.54M-81.44M-88.62M-95.70M-102.15M-109.88M23.56M13.29M11.37M4.87M-1.65M-18.99M-11.31M8.90M1.83M3.82M1.64M-1.44M7.94M18.85M
Liabilities and Shareholders Equity
96.51M81.26M70.81M61.32M22.66M41.77M37.62M30.99M27.15M24.48M15.75M38.39M28.18M28.14M29.53M28.28M25.86M22.69M31.33M39.60M
Treasury Stock
0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M
Retained Earnings
-215.14M-229.40M-238.51M-247.50M-107.01M-258.50M-122.60M-133.30M-142.20M-154.03M-161.30M-180.10M-194.10M-205.31M-215.90M-226.00M-233.67M-245.50M-253.71M-261.70M
Preferred Shares
4,997.92M
Treasury Shares
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M

Elicio Therapeutics Balance Sheet API

Pull Elicio Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ELTX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY